These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30302537)

  • 1. [Psychiatric pharmacotherapy of older individuals with severe mental illness].
    Lange-Asschenfeldt C
    Z Gerontol Geriatr; 2018 Nov; 51(7):770-778. PubMed ID: 30302537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for addressing adherence problems in patients with serious and persistent mental illness: recommendations from the expert consensus guidelines.
    Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP
    J Psychiatr Pract; 2010 Sep; 16(5):306-24. PubMed ID: 20859108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
    Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP;
    J Clin Psychiatry; 2009; 70 Suppl 4():1-46; quiz 47-8. PubMed ID: 19686636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association between mental illness, obesity and metabolic syndrome. Effect of the treatment with psychotropic drugs].
    Wikinski S
    Vertex; 2018 Mar; 29(138):120-127. PubMed ID: 30605184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric Medication Changes Associated With Increased Rate of Medical Readmissions in Patients With Serious Mental Illness.
    Germack HD; Weissinger G; Bizhanova Z; Martsolf GR
    J Nerv Ment Dis; 2021 Mar; 209(3):166-173. PubMed ID: 33315795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of HIV and psychotropic medications among persons with serious mental illness and HIV/AIDS.
    Lee S; Rothbard AB; Noll E; Blank MB
    Adm Policy Ment Health; 2011 Sep; 38(5):335-44. PubMed ID: 20976619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sociodemographic and clinical correlates of sexual dysfunction among psychiatric outpatients receiving common psychotropic medications in a Neuropsychiatric Hospital in Northern Nigeria.
    Olisah VO; Sheikh TL; Abah ER; Mahmud-Ajeigbe AF
    Niger J Clin Pract; 2016; 19(6):799-806. PubMed ID: 27811454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and length of hospital stay among older adults with bipolar disorder, schizophrenia or schizoaffective disorder, depression, and dementia.
    Sajatovic M; Friedman SH; Sabharwal J; Bingham CR
    J Geriatr Psychiatry Neurol; 2004 Mar; 17(1):3-8. PubMed ID: 15018690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe mental disorders and vaccinations - a systematic review.
    Bonkat N; Fellendorf FT; Dalkner N; Reininghaus EZ
    World J Biol Psychiatry; 2022 Sep; 23(7):501-516. PubMed ID: 35014937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Psychotropic drug use and correspondence with psychiatric diagnoses in the mental health in the general population survey].
    Grolleau A; Cougnard A; Bégaud B; Verdoux H
    Encephale; 2008 Sep; 34(4):352-9. PubMed ID: 18922237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzodiazepine prescription practices and substance abuse in persons with severe mental illness.
    Clark RE; Xie H; Brunette MF
    J Clin Psychiatry; 2004 Feb; 65(2):151-5. PubMed ID: 15003066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel psychoactive substances (NPS) use in severe mental illness (SMI) patients: Potential changes in the phenomenology of psychiatric diseases.
    Bersani G; Prevete E
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28657186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism.
    Misra M; Papakostas GI; Klibanski A
    J Clin Psychiatry; 2004 Dec; 65(12):1607-18; quiz 1590, 1760-1. PubMed ID: 15641865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of previously undiagnosed psychiatric disorders in persons with developmental disabilities decreased or eliminated self-injurious behavior.
    Tsiouris JA; Cohen IL; Patti PJ; Korosh WM
    J Clin Psychiatry; 2003 Sep; 64(9):1081-90. PubMed ID: 14628984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychiatric symptoms of fragile X syndrome: pathophysiology and pharmacotherapy.
    Tsiouris JA; Brown WT
    CNS Drugs; 2004; 18(11):687-703. PubMed ID: 15330685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn. Committee on Drugs. American Academy of Pediatrics.
    Pediatrics; 2000 Apr; 105(4 Pt 1):880-7. PubMed ID: 10742343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Deaths in a Tunisian psychiatric hospital: an eleven-year retrospective study].
    Zgueb Y; Jomli R; Ouertani A; Hechmi S; Ouanes S; Nacef F; Banaser A
    Encephale; 2014 Oct; 40(5):416-22. PubMed ID: 25132014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical treatment of psychiatric patients: possible polypharmacy problems.
    Norton JC; Ludwig AM
    Hosp Community Psychiatry; 1982 Apr; 33(4):305-7. PubMed ID: 7076147
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.